Spain could have in December nail three million dose of the Covid-19 vaccine being developed by the University of Oxford and the company AstraZeneca, as long as "the clinical tests exceed the due guarantees." This was announced this Monday by the Minister of Health, Salvador Illa, in the first ‘Health Observatory’, organized by “El Español”.
He also recalled that all European countries have signed a memorandum for the joint purchase of vaccines and equitable distribution of the same, in order that the doses arrive at the same time and in a "proportional" way to the population of each region.
Illa has advanced that Europe will buy a minimum of seven vaccines and a maximum of nine, although for the moment the contract has only been signed with the AstraZeneca company because it is the one with the most advanced tests.
"If the clinical analyzes exceed the due guarantees, as of December they would be in a position to supply doses. Europe will receive about 30 million doses and Spain would receive about three million," the minister declared, to clarify that it is a vaccine that It would foreseeably need two doses and that, if all goes well, in January there could be a regular supply.
Regarding the future vaccination strategy of Covid-19, Illa indicated that this Wednesday a working group, which will include the autonomous communities, scientific societies and experts, will be launched to decide which population will be prioritized. "The only requirement is that what is decided is also coordinated at the European level."
However, the minister has commented that "common sense" indicates that the first people to receive the vaccine will be those with a increased risk of Covid-19 seriously or those who work in contact with the most vulnerable groups.